Start
•
Completion

Safety and Tolerability of DMT in Healthy Adults

CompletedRegisteredCTG

Phase I, double-blind, randomised, placebo-controlled crossover in healthy volunteers (n=25) comparing inhaled DMT 60 mg with a 1 mg placebo-like inhalation across two sessions on the same day.

Details

Randomised, double-blind, placebo-controlled crossover assessing acute and subacute effects of inhaled N,N‑Dimethyltryptamine in healthy adults; each participant receives two inhalation sessions (DMT 60 mg and placebo-like 1 mg) the same day.

Primary focus is safety and tolerability with monitoring of vital signs, respiratory status, adverse events, and clinical assessments at acute and follow-up timepoints.

Topics:Healthy Volunteers

Registry

Registry linkNCT05901012